nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—NFKBIA—pancreatic cancer	0.0305	0.557	CrCbGaD
Nitazoxanide—Acetylsalicylic acid—TP53—pancreatic cancer	0.0135	0.247	CrCbGaD
Nitazoxanide—Meloxicam—PTGS2—pancreatic cancer	0.0046	0.084	CrCbGaD
Nitazoxanide—Salsalate—PTGS2—pancreatic cancer	0.00353	0.0646	CrCbGaD
Nitazoxanide—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00279	0.00295	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00279	0.00295	CcSEcCtD
Nitazoxanide—Malaise—Irinotecan—pancreatic cancer	0.00279	0.00295	CcSEcCtD
Nitazoxanide—Anaemia—Gemcitabine—pancreatic cancer	0.00278	0.00294	CcSEcCtD
Nitazoxanide—Syncope—Irinotecan—pancreatic cancer	0.00277	0.00293	CcSEcCtD
Nitazoxanide—Insomnia—Sunitinib—pancreatic cancer	0.00277	0.00293	CcSEcCtD
Nitazoxanide—Anaemia—Fluorouracil—pancreatic cancer	0.00273	0.00289	CcSEcCtD
Nitazoxanide—Loss of consciousness—Irinotecan—pancreatic cancer	0.00272	0.00287	CcSEcCtD
Nitazoxanide—Malaise—Gemcitabine—pancreatic cancer	0.00271	0.00287	CcSEcCtD
Nitazoxanide—Dyspepsia—Sunitinib—pancreatic cancer	0.00269	0.00285	CcSEcCtD
Nitazoxanide—Hypertension—Irinotecan—pancreatic cancer	0.00267	0.00282	CcSEcCtD
Nitazoxanide—Decreased appetite—Sunitinib—pancreatic cancer	0.00266	0.00281	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—PTGS2—pancreatic cancer	0.00264	0.0482	CrCbGaD
Nitazoxanide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00263	0.00279	CcSEcCtD
Nitazoxanide—Constipation—Sunitinib—pancreatic cancer	0.00262	0.00277	CcSEcCtD
Nitazoxanide—Pain—Sunitinib—pancreatic cancer	0.00262	0.00277	CcSEcCtD
Nitazoxanide—Discomfort—Irinotecan—pancreatic cancer	0.0026	0.00275	CcSEcCtD
Nitazoxanide—Hypertension—Gemcitabine—pancreatic cancer	0.0026	0.00275	CcSEcCtD
Nitazoxanide—Epistaxis—Docetaxel—pancreatic cancer	0.00258	0.00273	CcSEcCtD
Nitazoxanide—Asthenia—Tamoxifen—pancreatic cancer	0.00256	0.00271	CcSEcCtD
Nitazoxanide—Myalgia—Gemcitabine—pancreatic cancer	0.00256	0.00271	CcSEcCtD
Nitazoxanide—Increased appetite—Epirubicin—pancreatic cancer	0.00255	0.00269	CcSEcCtD
Nitazoxanide—Asthenia—Erlotinib—pancreatic cancer	0.00254	0.00268	CcSEcCtD
Nitazoxanide—Discomfort—Gemcitabine—pancreatic cancer	0.00253	0.00268	CcSEcCtD
Nitazoxanide—Pruritus—Tamoxifen—pancreatic cancer	0.00253	0.00267	CcSEcCtD
Nitazoxanide—Oedema—Irinotecan—pancreatic cancer	0.00252	0.00267	CcSEcCtD
Nitazoxanide—Myalgia—Fluorouracil—pancreatic cancer	0.00252	0.00266	CcSEcCtD
Nitazoxanide—Infection—Irinotecan—pancreatic cancer	0.0025	0.00265	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.0025	0.00265	CcSEcCtD
Nitazoxanide—Pruritus—Erlotinib—pancreatic cancer	0.0025	0.00265	CcSEcCtD
Nitazoxanide—Discomfort—Fluorouracil—pancreatic cancer	0.00249	0.00263	CcSEcCtD
Nitazoxanide—Shock—Irinotecan—pancreatic cancer	0.00248	0.00262	CcSEcCtD
Nitazoxanide—Rhinitis—Docetaxel—pancreatic cancer	0.00246	0.0026	CcSEcCtD
Nitazoxanide—Oedema—Gemcitabine—pancreatic cancer	0.00246	0.0026	CcSEcCtD
Nitazoxanide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00245	0.00259	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00244	0.00258	CcSEcCtD
Nitazoxanide—Infection—Gemcitabine—pancreatic cancer	0.00244	0.00258	CcSEcCtD
Nitazoxanide—Pharyngitis—Docetaxel—pancreatic cancer	0.00243	0.00258	CcSEcCtD
Nitazoxanide—Body temperature increased—Sunitinib—pancreatic cancer	0.00242	0.00256	CcSEcCtD
Nitazoxanide—Abdominal pain—Sunitinib—pancreatic cancer	0.00242	0.00256	CcSEcCtD
Nitazoxanide—Diarrhoea—Erlotinib—pancreatic cancer	0.00242	0.00256	CcSEcCtD
Nitazoxanide—Oedema—Fluorouracil—pancreatic cancer	0.00241	0.00255	CcSEcCtD
Nitazoxanide—Anorexia—Irinotecan—pancreatic cancer	0.0024	0.00254	CcSEcCtD
Nitazoxanide—Infection—Fluorouracil—pancreatic cancer	0.0024	0.00254	CcSEcCtD
Nitazoxanide—Dizziness—Tamoxifen—pancreatic cancer	0.00236	0.0025	CcSEcCtD
Nitazoxanide—Tachycardia—Fluorouracil—pancreatic cancer	0.00236	0.00249	CcSEcCtD
Nitazoxanide—Increased appetite—Doxorubicin—pancreatic cancer	0.00236	0.00249	CcSEcCtD
Nitazoxanide—Anorexia—Gemcitabine—pancreatic cancer	0.00234	0.00248	CcSEcCtD
Nitazoxanide—Dizziness—Erlotinib—pancreatic cancer	0.00234	0.00247	CcSEcCtD
Nitazoxanide—Anorexia—Fluorouracil—pancreatic cancer	0.0023	0.00244	CcSEcCtD
Nitazoxanide—Insomnia—Irinotecan—pancreatic cancer	0.00228	0.00241	CcSEcCtD
Nitazoxanide—Vomiting—Tamoxifen—pancreatic cancer	0.00227	0.0024	CcSEcCtD
Nitazoxanide—Hypersensitivity—Sunitinib—pancreatic cancer	0.00226	0.00239	CcSEcCtD
Nitazoxanide—Rash—Tamoxifen—pancreatic cancer	0.00225	0.00238	CcSEcCtD
Nitazoxanide—Dermatitis—Tamoxifen—pancreatic cancer	0.00225	0.00238	CcSEcCtD
Nitazoxanide—Vomiting—Erlotinib—pancreatic cancer	0.00225	0.00238	CcSEcCtD
Nitazoxanide—Somnolence—Irinotecan—pancreatic cancer	0.00224	0.00237	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00224	0.00237	CcSEcCtD
Nitazoxanide—Headache—Tamoxifen—pancreatic cancer	0.00224	0.00237	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00224	0.00237	CcSEcCtD
Nitazoxanide—Rash—Erlotinib—pancreatic cancer	0.00223	0.00236	CcSEcCtD
Nitazoxanide—Dermatitis—Erlotinib—pancreatic cancer	0.00223	0.00236	CcSEcCtD
Nitazoxanide—Insomnia—Gemcitabine—pancreatic cancer	0.00222	0.00235	CcSEcCtD
Nitazoxanide—Dyspepsia—Irinotecan—pancreatic cancer	0.00222	0.00235	CcSEcCtD
Nitazoxanide—Headache—Erlotinib—pancreatic cancer	0.00222	0.00234	CcSEcCtD
Nitazoxanide—Chills—Docetaxel—pancreatic cancer	0.0022	0.00233	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.0022	0.00233	CcSEcCtD
Nitazoxanide—Asthenia—Sunitinib—pancreatic cancer	0.0022	0.00232	CcSEcCtD
Nitazoxanide—Decreased appetite—Irinotecan—pancreatic cancer	0.00219	0.00232	CcSEcCtD
Nitazoxanide—Insomnia—Fluorouracil—pancreatic cancer	0.00218	0.00231	CcSEcCtD
Nitazoxanide—Somnolence—Gemcitabine—pancreatic cancer	0.00218	0.00231	CcSEcCtD
Nitazoxanide—Pruritus—Sunitinib—pancreatic cancer	0.00217	0.00229	CcSEcCtD
Nitazoxanide—Pain—Irinotecan—pancreatic cancer	0.00216	0.00228	CcSEcCtD
Nitazoxanide—Constipation—Irinotecan—pancreatic cancer	0.00216	0.00228	CcSEcCtD
Nitazoxanide—Somnolence—Fluorouracil—pancreatic cancer	0.00215	0.00227	CcSEcCtD
Nitazoxanide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00214	0.00226	CcSEcCtD
Nitazoxanide—Dyspepsia—Fluorouracil—pancreatic cancer	0.00213	0.00225	CcSEcCtD
Nitazoxanide—Nausea—Tamoxifen—pancreatic cancer	0.00212	0.00225	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.00211	0.00223	CcSEcCtD
Nitazoxanide—Constipation—Gemcitabine—pancreatic cancer	0.0021	0.00222	CcSEcCtD
Nitazoxanide—Pain—Gemcitabine—pancreatic cancer	0.0021	0.00222	CcSEcCtD
Nitazoxanide—Nausea—Erlotinib—pancreatic cancer	0.0021	0.00222	CcSEcCtD
Nitazoxanide—Decreased appetite—Fluorouracil—pancreatic cancer	0.0021	0.00222	CcSEcCtD
Nitazoxanide—Diarrhoea—Sunitinib—pancreatic cancer	0.00209	0.00222	CcSEcCtD
Nitazoxanide—Feeling abnormal—Irinotecan—pancreatic cancer	0.00208	0.0022	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00207	0.00219	CcSEcCtD
Nitazoxanide—Influenza—Epirubicin—pancreatic cancer	0.00207	0.00219	CcSEcCtD
Nitazoxanide—Back pain—Docetaxel—pancreatic cancer	0.00207	0.00219	CcSEcCtD
Nitazoxanide—Pain—Fluorouracil—pancreatic cancer	0.00207	0.00218	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00206	0.00218	CcSEcCtD
Nitazoxanide—Muscle spasms—Docetaxel—pancreatic cancer	0.00205	0.00217	CcSEcCtD
Nitazoxanide—Dizziness—Sunitinib—pancreatic cancer	0.00202	0.00214	CcSEcCtD
Nitazoxanide—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00202	0.00214	CcSEcCtD
Nitazoxanide—Abdominal pain—Irinotecan—pancreatic cancer	0.00199	0.00211	CcSEcCtD
Nitazoxanide—Body temperature increased—Irinotecan—pancreatic cancer	0.00199	0.00211	CcSEcCtD
Nitazoxanide—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00199	0.00211	CcSEcCtD
Nitazoxanide—Anaemia—Docetaxel—pancreatic cancer	0.00197	0.00209	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.00195	0.00207	CcSEcCtD
Nitazoxanide—Vomiting—Sunitinib—pancreatic cancer	0.00195	0.00206	CcSEcCtD
Nitazoxanide—Body temperature increased—Gemcitabine—pancreatic cancer	0.00194	0.00205	CcSEcCtD
Nitazoxanide—Dysuria—Epirubicin—pancreatic cancer	0.00193	0.00205	CcSEcCtD
Nitazoxanide—Rash—Sunitinib—pancreatic cancer	0.00193	0.00204	CcSEcCtD
Nitazoxanide—Dermatitis—Sunitinib—pancreatic cancer	0.00193	0.00204	CcSEcCtD
Nitazoxanide—Headache—Sunitinib—pancreatic cancer	0.00192	0.00203	CcSEcCtD
Nitazoxanide—Syncope—Docetaxel—pancreatic cancer	0.00192	0.00203	CcSEcCtD
Nitazoxanide—Influenza—Doxorubicin—pancreatic cancer	0.00191	0.00202	CcSEcCtD
Nitazoxanide—Body temperature increased—Fluorouracil—pancreatic cancer	0.00191	0.00202	CcSEcCtD
Nitazoxanide—Loss of consciousness—Docetaxel—pancreatic cancer	0.00188	0.00199	CcSEcCtD
Nitazoxanide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00186	0.00197	CcSEcCtD
Nitazoxanide—Hypertension—Docetaxel—pancreatic cancer	0.00184	0.00195	CcSEcCtD
Nitazoxanide—Myalgia—Docetaxel—pancreatic cancer	0.00182	0.00192	CcSEcCtD
Nitazoxanide—Nausea—Sunitinib—pancreatic cancer	0.00182	0.00192	CcSEcCtD
Nitazoxanide—Asthenia—Irinotecan—pancreatic cancer	0.00181	0.00191	CcSEcCtD
Nitazoxanide—Dysuria—Doxorubicin—pancreatic cancer	0.00179	0.00189	CcSEcCtD
Nitazoxanide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00178	0.00188	CcSEcCtD
Nitazoxanide—Dry mouth—Docetaxel—pancreatic cancer	0.00178	0.00188	CcSEcCtD
Nitazoxanide—Asthenia—Gemcitabine—pancreatic cancer	0.00176	0.00186	CcSEcCtD
Nitazoxanide—Oedema—Docetaxel—pancreatic cancer	0.00174	0.00184	CcSEcCtD
Nitazoxanide—Epistaxis—Epirubicin—pancreatic cancer	0.00174	0.00184	CcSEcCtD
Nitazoxanide—Pruritus—Gemcitabine—pancreatic cancer	0.00174	0.00184	CcSEcCtD
Nitazoxanide—Infection—Docetaxel—pancreatic cancer	0.00173	0.00183	CcSEcCtD
Nitazoxanide—Diarrhoea—Irinotecan—pancreatic cancer	0.00173	0.00183	CcSEcCtD
Nitazoxanide—Shock—Docetaxel—pancreatic cancer	0.00171	0.00181	CcSEcCtD
Nitazoxanide—Pruritus—Fluorouracil—pancreatic cancer	0.00171	0.00181	CcSEcCtD
Nitazoxanide—Tachycardia—Docetaxel—pancreatic cancer	0.0017	0.0018	CcSEcCtD
Nitazoxanide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00168	0.00178	CcSEcCtD
Nitazoxanide—Dizziness—Irinotecan—pancreatic cancer	0.00167	0.00176	CcSEcCtD
Nitazoxanide—Anorexia—Docetaxel—pancreatic cancer	0.00166	0.00176	CcSEcCtD
Nitazoxanide—Rhinitis—Epirubicin—pancreatic cancer	0.00166	0.00175	CcSEcCtD
Nitazoxanide—Diarrhoea—Fluorouracil—pancreatic cancer	0.00165	0.00175	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00165	0.00174	CcSEcCtD
Nitazoxanide—Pharyngitis—Epirubicin—pancreatic cancer	0.00164	0.00174	CcSEcCtD
Nitazoxanide—Epistaxis—Doxorubicin—pancreatic cancer	0.00161	0.0017	CcSEcCtD
Nitazoxanide—Vomiting—Irinotecan—pancreatic cancer	0.0016	0.0017	CcSEcCtD
Nitazoxanide—Dizziness—Fluorouracil—pancreatic cancer	0.0016	0.00169	CcSEcCtD
Nitazoxanide—Rash—Irinotecan—pancreatic cancer	0.00159	0.00168	CcSEcCtD
Nitazoxanide—Dermatitis—Irinotecan—pancreatic cancer	0.00159	0.00168	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00159	0.00168	CcSEcCtD
Nitazoxanide—Headache—Irinotecan—pancreatic cancer	0.00158	0.00167	CcSEcCtD
Nitazoxanide—Insomnia—Docetaxel—pancreatic cancer	0.00158	0.00167	CcSEcCtD
Nitazoxanide—Vomiting—Gemcitabine—pancreatic cancer	0.00156	0.00165	CcSEcCtD
Nitazoxanide—Somnolence—Docetaxel—pancreatic cancer	0.00155	0.00164	CcSEcCtD
Nitazoxanide—Rash—Gemcitabine—pancreatic cancer	0.00155	0.00164	CcSEcCtD
Nitazoxanide—Dermatitis—Gemcitabine—pancreatic cancer	0.00155	0.00164	CcSEcCtD
Nitazoxanide—Headache—Gemcitabine—pancreatic cancer	0.00154	0.00163	CcSEcCtD
Nitazoxanide—Vomiting—Fluorouracil—pancreatic cancer	0.00154	0.00162	CcSEcCtD
Nitazoxanide—Rhinitis—Doxorubicin—pancreatic cancer	0.00153	0.00162	CcSEcCtD
Nitazoxanide—Dyspepsia—Docetaxel—pancreatic cancer	0.00153	0.00162	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.00152	0.00161	CcSEcCtD
Nitazoxanide—Rash—Fluorouracil—pancreatic cancer	0.00152	0.00161	CcSEcCtD
Nitazoxanide—Dermatitis—Fluorouracil—pancreatic cancer	0.00152	0.00161	CcSEcCtD
Nitazoxanide—Pharyngitis—Doxorubicin—pancreatic cancer	0.00152	0.00161	CcSEcCtD
Nitazoxanide—Decreased appetite—Docetaxel—pancreatic cancer	0.00152	0.0016	CcSEcCtD
Nitazoxanide—Headache—Fluorouracil—pancreatic cancer	0.00151	0.0016	CcSEcCtD
Nitazoxanide—Nausea—Irinotecan—pancreatic cancer	0.0015	0.00158	CcSEcCtD
Nitazoxanide—Pain—Docetaxel—pancreatic cancer	0.00149	0.00158	CcSEcCtD
Nitazoxanide—Constipation—Docetaxel—pancreatic cancer	0.00149	0.00158	CcSEcCtD
Nitazoxanide—Chills—Epirubicin—pancreatic cancer	0.00148	0.00157	CcSEcCtD
Nitazoxanide—Nausea—Gemcitabine—pancreatic cancer	0.00146	0.00154	CcSEcCtD
Nitazoxanide—Feeling abnormal—Docetaxel—pancreatic cancer	0.00144	0.00152	CcSEcCtD
Nitazoxanide—Nausea—Fluorouracil—pancreatic cancer	0.00143	0.00152	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00143	0.00151	CcSEcCtD
Nitazoxanide—Flatulence—Epirubicin—pancreatic cancer	0.00142	0.0015	CcSEcCtD
Nitazoxanide—Back pain—Epirubicin—pancreatic cancer	0.00139	0.00147	CcSEcCtD
Nitazoxanide—Muscle spasms—Epirubicin—pancreatic cancer	0.00138	0.00147	CcSEcCtD
Nitazoxanide—Abdominal pain—Docetaxel—pancreatic cancer	0.00138	0.00146	CcSEcCtD
Nitazoxanide—Body temperature increased—Docetaxel—pancreatic cancer	0.00138	0.00146	CcSEcCtD
Nitazoxanide—Chills—Doxorubicin—pancreatic cancer	0.00137	0.00145	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00134	0.00141	CcSEcCtD
Nitazoxanide—Anaemia—Epirubicin—pancreatic cancer	0.00133	0.00141	CcSEcCtD
Nitazoxanide—Flatulence—Doxorubicin—pancreatic cancer	0.00131	0.00139	CcSEcCtD
Nitazoxanide—Malaise—Epirubicin—pancreatic cancer	0.0013	0.00137	CcSEcCtD
Nitazoxanide—Syncope—Epirubicin—pancreatic cancer	0.00129	0.00137	CcSEcCtD
Nitazoxanide—Back pain—Doxorubicin—pancreatic cancer	0.00129	0.00136	CcSEcCtD
Nitazoxanide—Hypersensitivity—Docetaxel—pancreatic cancer	0.00128	0.00136	CcSEcCtD
Nitazoxanide—Muscle spasms—Doxorubicin—pancreatic cancer	0.00128	0.00136	CcSEcCtD
Nitazoxanide—Loss of consciousness—Epirubicin—pancreatic cancer	0.00127	0.00134	CcSEcCtD
Nitazoxanide—Asthenia—Docetaxel—pancreatic cancer	0.00125	0.00132	CcSEcCtD
Nitazoxanide—Hypertension—Epirubicin—pancreatic cancer	0.00124	0.00132	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00124	0.00131	CcSEcCtD
Nitazoxanide—Pruritus—Docetaxel—pancreatic cancer	0.00123	0.0013	CcSEcCtD
Nitazoxanide—Anaemia—Doxorubicin—pancreatic cancer	0.00123	0.0013	CcSEcCtD
Nitazoxanide—Myalgia—Epirubicin—pancreatic cancer	0.00123	0.0013	CcSEcCtD
Nitazoxanide—Discomfort—Epirubicin—pancreatic cancer	0.00121	0.00128	CcSEcCtD
Nitazoxanide—Malaise—Doxorubicin—pancreatic cancer	0.0012	0.00127	CcSEcCtD
Nitazoxanide—Dry mouth—Epirubicin—pancreatic cancer	0.0012	0.00127	CcSEcCtD
Nitazoxanide—Syncope—Doxorubicin—pancreatic cancer	0.0012	0.00126	CcSEcCtD
Nitazoxanide—Diarrhoea—Docetaxel—pancreatic cancer	0.00119	0.00126	CcSEcCtD
Nitazoxanide—Oedema—Epirubicin—pancreatic cancer	0.00118	0.00124	CcSEcCtD
Nitazoxanide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00117	0.00124	CcSEcCtD
Nitazoxanide—Infection—Epirubicin—pancreatic cancer	0.00117	0.00124	CcSEcCtD
Nitazoxanide—Shock—Epirubicin—pancreatic cancer	0.00116	0.00122	CcSEcCtD
Nitazoxanide—Dizziness—Docetaxel—pancreatic cancer	0.00115	0.00122	CcSEcCtD
Nitazoxanide—Hypertension—Doxorubicin—pancreatic cancer	0.00115	0.00122	CcSEcCtD
Nitazoxanide—Tachycardia—Epirubicin—pancreatic cancer	0.00115	0.00121	CcSEcCtD
Nitazoxanide—Myalgia—Doxorubicin—pancreatic cancer	0.00113	0.0012	CcSEcCtD
Nitazoxanide—Discomfort—Doxorubicin—pancreatic cancer	0.00112	0.00119	CcSEcCtD
Nitazoxanide—Anorexia—Epirubicin—pancreatic cancer	0.00112	0.00119	CcSEcCtD
Nitazoxanide—Dry mouth—Doxorubicin—pancreatic cancer	0.00111	0.00117	CcSEcCtD
Nitazoxanide—Vomiting—Docetaxel—pancreatic cancer	0.00111	0.00117	CcSEcCtD
Nitazoxanide—Rash—Docetaxel—pancreatic cancer	0.0011	0.00116	CcSEcCtD
Nitazoxanide—Dermatitis—Docetaxel—pancreatic cancer	0.0011	0.00116	CcSEcCtD
Nitazoxanide—Headache—Docetaxel—pancreatic cancer	0.00109	0.00116	CcSEcCtD
Nitazoxanide—Oedema—Doxorubicin—pancreatic cancer	0.00109	0.00115	CcSEcCtD
Nitazoxanide—Infection—Doxorubicin—pancreatic cancer	0.00108	0.00114	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00107	0.00113	CcSEcCtD
Nitazoxanide—Shock—Doxorubicin—pancreatic cancer	0.00107	0.00113	CcSEcCtD
Nitazoxanide—Insomnia—Epirubicin—pancreatic cancer	0.00106	0.00112	CcSEcCtD
Nitazoxanide—Tachycardia—Doxorubicin—pancreatic cancer	0.00106	0.00112	CcSEcCtD
Nitazoxanide—Somnolence—Epirubicin—pancreatic cancer	0.00105	0.00111	CcSEcCtD
Nitazoxanide—Anorexia—Doxorubicin—pancreatic cancer	0.00104	0.0011	CcSEcCtD
Nitazoxanide—Nausea—Docetaxel—pancreatic cancer	0.00104	0.0011	CcSEcCtD
Nitazoxanide—Dyspepsia—Epirubicin—pancreatic cancer	0.00103	0.00109	CcSEcCtD
Nitazoxanide—Decreased appetite—Epirubicin—pancreatic cancer	0.00102	0.00108	CcSEcCtD
Nitazoxanide—Pain—Epirubicin—pancreatic cancer	0.00101	0.00106	CcSEcCtD
Nitazoxanide—Constipation—Epirubicin—pancreatic cancer	0.00101	0.00106	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000991	0.00105	CcSEcCtD
Nitazoxanide—Insomnia—Doxorubicin—pancreatic cancer	0.000984	0.00104	CcSEcCtD
Nitazoxanide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000969	0.00102	CcSEcCtD
Nitazoxanide—Somnolence—Doxorubicin—pancreatic cancer	0.000967	0.00102	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000961	0.00102	CcSEcCtD
Nitazoxanide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000958	0.00101	CcSEcCtD
Nitazoxanide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000946	0.001	CcSEcCtD
Nitazoxanide—Pain—Doxorubicin—pancreatic cancer	0.00093	0.000984	CcSEcCtD
Nitazoxanide—Constipation—Doxorubicin—pancreatic cancer	0.00093	0.000984	CcSEcCtD
Nitazoxanide—Abdominal pain—Epirubicin—pancreatic cancer	0.000929	0.000983	CcSEcCtD
Nitazoxanide—Body temperature increased—Epirubicin—pancreatic cancer	0.000929	0.000983	CcSEcCtD
Nitazoxanide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000896	0.000948	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000889	0.000941	CcSEcCtD
Nitazoxanide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000866	0.000916	CcSEcCtD
Nitazoxanide—Body temperature increased—Doxorubicin—pancreatic cancer	0.00086	0.00091	CcSEcCtD
Nitazoxanide—Abdominal pain—Doxorubicin—pancreatic cancer	0.00086	0.00091	CcSEcCtD
Nitazoxanide—Asthenia—Epirubicin—pancreatic cancer	0.000843	0.000892	CcSEcCtD
Nitazoxanide—Pruritus—Epirubicin—pancreatic cancer	0.000832	0.00088	CcSEcCtD
Nitazoxanide—Diarrhoea—Epirubicin—pancreatic cancer	0.000804	0.000851	CcSEcCtD
Nitazoxanide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000801	0.000848	CcSEcCtD
Nitazoxanide—Asthenia—Doxorubicin—pancreatic cancer	0.00078	0.000826	CcSEcCtD
Nitazoxanide—Dizziness—Epirubicin—pancreatic cancer	0.000777	0.000822	CcSEcCtD
Nitazoxanide—Pruritus—Doxorubicin—pancreatic cancer	0.00077	0.000814	CcSEcCtD
Nitazoxanide—Vomiting—Epirubicin—pancreatic cancer	0.000747	0.000791	CcSEcCtD
Nitazoxanide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000744	0.000787	CcSEcCtD
Nitazoxanide—Rash—Epirubicin—pancreatic cancer	0.000741	0.000784	CcSEcCtD
Nitazoxanide—Dermatitis—Epirubicin—pancreatic cancer	0.000741	0.000783	CcSEcCtD
Nitazoxanide—Headache—Epirubicin—pancreatic cancer	0.000736	0.000779	CcSEcCtD
Nitazoxanide—Dizziness—Doxorubicin—pancreatic cancer	0.000719	0.000761	CcSEcCtD
Nitazoxanide—Nausea—Epirubicin—pancreatic cancer	0.000698	0.000739	CcSEcCtD
Nitazoxanide—Vomiting—Doxorubicin—pancreatic cancer	0.000692	0.000732	CcSEcCtD
Nitazoxanide—Rash—Doxorubicin—pancreatic cancer	0.000686	0.000726	CcSEcCtD
Nitazoxanide—Dermatitis—Doxorubicin—pancreatic cancer	0.000685	0.000725	CcSEcCtD
Nitazoxanide—Headache—Doxorubicin—pancreatic cancer	0.000681	0.000721	CcSEcCtD
Nitazoxanide—Nausea—Doxorubicin—pancreatic cancer	0.000646	0.000684	CcSEcCtD
